S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B

Bibliographic Details
Main Authors: M. Tobiasson, T. Pandzic, J. Illman, L. Nilsson, S. Weström, K. Sollander, E. Ejerblad, A. Olsnes Kittang, G. Olesen, O. Werlenius, A. Björklund, J. Wiggh, C. lindholm, F. Lorentz, B. Rasmussen, J. Cammenga, D. Weber, D. Grönnås, M. Dimitriou, S. Kytölä, G. Walldin, P. Ljungman, K. Groenbeck, S. Mielke, S. E. Jacobsen, F. Ebeling, L. Cavelier, L. Smidstrup Friis, I. Dybedal, E. Hellström-Lindberg
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000843560.87168.a9

Similar Items

Similar Items